New horizons in cytotoxic therapeutic drug monitoring

In many cancers, cytotoxic drugs have only a marginal long-term effect and resistance develops quickly. Optimal dosing is needed and drawbacks exist with traditional dosing calculations. Therapeutic drug monitoring (TDM) using population-based methods may hold promise to optimise therapy.